Table 3.

Multilevel results identifying predictors of non-fatal overdose among female injection-drug users (n=653).

		Model 1			Model 2			Model 3
Within participant Fixed Effects	Parameter	OR	95% CI	p-value	OR	95% CI	p-value	OR	95% CI	p-value
Baseline Year 1-Intercept	β00	0.10	0.08,0.12	<0.001	0.04	0.03,0.06	<0.01	0.01	0.01,0.03	<0.01
Finished High School	β01							1.49	1.07,2.07	0.02
Gay or Bi	β02							1.59	1.12,2.25	0.01
Born outside Canada	β03							1.17	0.82,1.67	0.38
Age (≤20 years)	β04							2.68	1.14,6.29	0.02
ACCESS Cohort	β05							0.86	0.25,3.05	0.82
VIDUS Cohort	β06							0.88	0.51,1.51	0.64
Depressive Symptoms	β10				2.64	1.99,3.50	<0.01	2.23	1.65,3.00	<0.01
Homeless	B20							1.35	0.94,1.93	0.11
Support (ref: none)
1–2	B30							0.85	0.59,1.23	0.40
3 or more	B40							0.54	0.31,0.93	0.03
Relationship	B50							1.08	0.79,1.47	0.63
Welfare	B60							1.71	1.20,2.44	<0.01
Jail in the last 6 months	B70							1.31	0.77,2.22	0.32
HIV	B80							0.71	0.24,2.12	0.54
Alcohol Binge	B90							1.59	1.11,2.30	0.01
Heroin	B100							1.34	0.95,1.89	0.10
Cocaine	β110							1.84	1.29,2.62	<0.01
Speed	β120							1.14	0.80,1.62	0.47
Crystal Meth	β130							0.89	0.58,1.36	0.58
Morphine	β140							1.81	1.24,2.64	<0.01
Help Injecting	β150							1.04	0.65,1.66	0.89
Methadone	β160							0.87	0.64,1.20	0.40
Year 1	β170	0.64	0.45,0.93	0.02	0.68	0.47,1.00	0.05	0.72	0.48,1.08	0.11
Year 2	β180	0.58	0.42,0.80	<0.01	0.61	0.43,0.87	<0.01	0.63	0.43,0.91	0.01
Year 3	β190	0.45	0.32,0.64	<0.01	0.51	0.35,0.75	<0.01	0.51	0.34,0.77	<0.01
Year 4	β200	0.32	0.20,0.50	<0.01	0.38	0.23,0.63	<0.01	0.51	0.29,0.88	0.02